Presented by expert speakers, our webinars will give you advance insight into topics that will be covered at the event.
Can’t make the date? Still register to receive the webinar recording afterwards.
SmartLabs & Laboratory Informatics Webinar
Manual inventory management is decreasing your lab productivity by up to 97%
Wednesday 9th September 2020 | 2:00 PM BST / 3:00 PM CEST
Haydn Boehm, Head of Commercial Marketing – Connected Lab, Merck KGaA, Darmstadt, Germany
How current inventory management is impacting your productivity, resources, costs and capacity
Why this is important to rethink to meet productivity, regulatory and innovation goals
What can be done to change the status quo
Haydn Boehm is the Head of Commercial Marketing for Merck’s Connected Lab digital program and has over 20 years’ experience in marketing and business development within the life scientific sector. Haydn has a PhD in Organic Chemistry from the University of Nottingham, UK.
AI in Drug Development Webinar:
The Use Of BenevolentAI’s Platform To Identify And Validate Novel Targets For Neurological Diseases
Wednesday 13th May 2020 | 2pm UK time
Presented by Jackie Hunter, CE, Clinical and Strategic Partnerships, BenevolentAI
- This webinar will showcase BenevolentAI’s platform and describe how it can be used in different ways along the drug discovery and development process
- Specific examples will be described in the identification of novel targets for neurological diseases for which there are currently no good treatment options
Professor Jackie Hunter held senior positions at global pharmaceutical organisations including GSK, Proximagen and OI Pharma Partners before joining BenevolentAI as a Director in 2016. She brings vast academic and business experience in the biomedical and pharmaceutical sectors. She directs the application of BenevolentAI’s technology for clinical development and gives the company the insight it needs to operate its unique business model – one which sees it not only researching, but also developing the blueprint for new drugs.